The STEP 1 trial (Wilding et al., The Lancet, 2021) showed an average weight loss of 14.9% over 68 weeks versus 2.4% in the placebo group a landmark result that established semaglutide as the benchmark for GLP-1 weight loss
The Experts Behind Your Care At Dallas Therapy Alliance, we offer individualized therapy and psychiatric services to adults, adolescents, children, and families
Yes Treatment Length 5 to 10 Minutes Downtime None Locations Offered: Lees Summit & Overland Park Chronic fatigue Autoimmune concerns Skin disorders Low energy Signs of aging Consultation Every person is different, and we treat you that way
It is critical that state policies addressing the rise in polysubstance use and its link to increased risk of overdose span across prevention, harm reduction, and treatment strategies
Developmental exposure to a commercial PBDE mixture, DE-71: neurobehavioral, hormonal, and reproductive effects
A Western-style diet is one of the strongest risk factors for cholesterol gallstones